About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

102. Rubinstein-Taybi syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 4 / Drugs : 8 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Culture OF lymphoblastoid line from blood sample
   University Hospital, Bordeaux
      2019   -   NCT04122742   France
Depakine
   CHU de bordeaux
      -   Phase 2   EUCTR2011-003784-30-FR   France
EX-vivo approach concerning 25 patients
   University Hospital, Bordeaux
      2023   -   NCT05696912   France
Functional involvement OF identified epigenetic alterations
   University Hospital, Bordeaux
      2019   -   NCT04122742   France
Generation OF induced pluripotent stem cells (ipsc) from fibroblasts obtained BY skin biopsy
   University Hospital, Bordeaux
      2019   -   NCT04122742   France
Histone acetylation profiles OF cells OF SRT patients with crebbp mutations
   University Hospital, Bordeaux
      2019   -   NCT04122742   France
IN-vitro approach concerning 25 patients
   University Hospital, Bordeaux
      2023   -   NCT05696912   France
Sodium valproate
   University Hospital, Bordeaux
      2012   Phase 2   NCT01619644   France